Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Povidone-Iodine Nasal Swabsticks

Active
MN-2311-08Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Health Agency Medical Logistics Division, in coordination with the Defense Logistics Agency Troop Support Medical/Surgical Prime Vendor program, plans to issue a Sources Sought notification around March 30, 2024, for establishing a Qualified Suppliers Listing (QSL) for Povidone-Iodine Nasal Swabsticks. This notification is intended to gather information about potential suppliers of products designed for nasal decolonization, specifically sterile or nonsterile, single-use nasal swabsticks pre-saturated with 10% Povidone-Iodine, free of natural rubber latex. The scope excludes swabsticks intended for skin preparation or wound care. This effort aims to evaluate vendors and products to develop a QSL that will support a future Standardization Action leading to an Incentive Agreement within the Medical/Surgical Prime Vendor program, managed by DLA Troop Support. Vendors interested in participating must either hold or be in the process of obtaining a Distribution and Pricing Agreement (DAPA) as well as separate commercial agreements with current Prime Vendors such as Cardinal Health or Owens & Minor. Accounts must be active in the System for Award Management (SAM), and suppliers are required to provide a Commercial and Government Entity (CAGE) Code. All items proposed must be compliant with the Trade Agreements Act (TAA), unless no functionally equivalent products are available from compliant sources, and vendors must complete the DAPA TAA Certification. This notice is purely informational and not a request for proposals or qualifications; further detailed information and the formal QSL Announcement will be available electronically on SAM.gov upon release.

General Info

Defense Health Agency seeks suppliers for 10% Povidone-Iodine nasal swabsticks, latex-free, by March 2024.

NAICS

339113 - Surgical Appliance and Supplies Manufacturing

Place of Performance

Frederick, MD, 21702, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update
PhasePresolicitation
Posted

Presolicitation

Notice updated

Notice details unchanged. Attachments may have changed.

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts2 people available
OfficePHILADELPHIA, PA, 19111, USA
Office AddressPHILADELPHIA, PA, 19111, USA
Contacts
MMESO Enterprise Wide Standardization
Tara J. Perrien Contracting Officer

Full Description

Show more
The Defense Health Agency (DHA) Medical Logistics (MEDLOG) Division Medical Materiel Enterprise Standardization Office (MMESO) and Defense Logistics Agency (DLA) Troop Support Medical/Surgical Prime Vendor (MSPV) program anticipate issuing a Sources Sought notification for the establishment of a Qualified Suppliers Listing (QSL) for Povidone-Iodine Nasal Swabsticks through the SAM.gov website on or about 30 March 2024. This is not a request for quote or proposal. Examples of items for this Povidone-Iodine Nasal Swabsticks product line could include but are not limited to: sterile, nonsterile, single use, pre-saturated nasal swabsticks with 10% Povidone-Iodine, in packs of various quantities. The intended use of this product line is nasal decolonization. Products are not made with natural rubber latex. Povidone-Iodine Swabsticks products for skin preparation and wound care are excluded from the scope of this project The primary objective of this effort will be to solicit information and products for evaluation in order to create a QSL. The subject QSL will be the basis of a separate Standardization Action (SA) resulting in an Incentive Agreement (IA). This initiative will be part of the MSPV program which is executed by the DLA Troop Support, Directorate of Medical Materiel. To participate in the QSL process vendors must have or be in the process of obtaining a Distribution and Pricing Agreement (DAPA) and a separate commercial agreement with the current Medical/Surgical PV for each MMESO Area of Responsibility (AOR), i.e., Cardinal Health, and Owens & Minor. Vendors must validate that their account is Active in the System for Award Management (SAM) and provide Commercial and Government Entity (CAGE) Code. For additional information regarding DLA Troop Support's MSPV program, please access the DLA web site at https://www.medical.dla.mil. All items proposed to be included in this QSL must be on DAPA for the DLA Troop Support MSPV program. The MSPV Program requires that all items be manufactured in a Trade Agreements Act (TAA) Compliant Country (as defined by FAR 52.225-5), unless it is determined that no functionally equivalent item is available from a compliant source. To be eligible for inclusion in the proposed QSL, all vendors are required to complete the DAPA TAA Certification. Detailed information about the QSL requirements will be provided in the QSL Announcement. The purpose of this Notice of Intent to establish a Qualified Supplier List is to inform qualified entities interested in providing these services that the release of the QSL Announcement is imminent. Upon issuance of the QSL Announcement, all relevant information will be available electronically on the SAM.gov website. This Notice of Intent to establish a Qualified Supplier List is for information purposes only. This is not a request for submission of proposals or qualifications. RESPONSES OR OTHER INQUIRIES ARE NOT APPROPRIATE AT THIS TIME.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → DLA Troop Support

Same awarding agency

NAICS: 326199
New
Federal
Synopsis for Outserts (NSN - 4240-01-529-8327 & 4240-01-528-9288)
Solicitation # 015298327_015289288
Solicitation SPE8EG-26-R-0003 is an unrestricted, fixed-price with economic price adjustment, indefinite delivery/indefinite quantity contract issued by DLA Troop Support for the procurement of critical Chemical Biological Radiation and Nuclear Personal Protective Equipment. The requirement consists of two National Stock Numbers: Clear Assembly Outserts (NSN 4240-01-529-8327) and Laser Assembly Outserts (NSN 4240-01-528-9288). The contract structure includes a one-year base period with four one-year option periods. Delivery terms are FOB Origin, with inspection and acceptance also occurring at origin. Price is the sole evaluated factor for award. Avon Protection Systems Incorporated is the approved source for these items. Due to the critical nature of the application, only approved part numbers are authorized unless a complete data package for an alternate is provided for evaluation. The procurement is subject to strict export controls under ITAR and EAR, requiring offerors to have an approved US/Canada Joint Certification Program certification and DLA authorization to access technical data. Additionally, while Cybersecurity Maturity Model Certification Level 2 requirements apply to these materials, they are not required for the initial award but will be necessary for future continued performance. The solicitation closing date has been extended multiple times and is currently set for November 13, 2026, at 3:00 PM EDT.
All Other Plastics Product Manufacturing

POSTED

about 14 hours ago

DEADLINE

in 15 days
View Details
NAICS: 325412
New
Federal
Atropine Auto-Injector
Solicitation # SPE2DP-27-R-ATRO
DLA Troop Support is conducting market research via a sources sought notice for the procurement of Atropine Auto-Injectors under solicitation SPE2DP-27-ATRO. The agency intends to award a firm-fixed price, indefinite delivery, indefinite quantity contract consisting of a one-year base term and four one-year option terms. The required devices must deliver 1.67 mg of atropine base (equivalent to 2 mg atropine sulfate) and be 99.5 percent reliable, with a dispensing time of 0.5 seconds and an activation force between 0.90 and 3.60 kg. All products must be FDA approved per NDA No. 212319, comply with USP sterility standards, and maintain a minimum shelf life of 24 months upon delivery to DLA Distribution Susquehanna in New Cumberland, Pennsylvania. Strict packaging and marking requirements are mandated, including individual sealed polyethylene bags, intermediate boxes of 40 units, and exterior containers of 480 units, all conforming to MIL-STD-2073-1 and ASTM D4169-16. Labels must include specific dosage, storage, and usage instructions for nerve agent and insecticide poisoning. Interested respondents must provide their CAGE code, business size under NAICS 325412, and certification of commerciality per FAR 2.101. Manufacturers must submit FDA registration, while authorized distributors must provide a letter of commitment from the manufacturer. Responses are due by December 1, 2026.
Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

in about 1 month
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS